NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
Stock Information for NovaBay Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.